ORIC Pharmaceuticals Funding & Investors
South San Francisco, CA
ORIC Pharmaceuticals, Inc. operates as a pharmaceutical company. The Company discovers and develops novel therapies for the treatment of cancer diseases. ORIC Pharmaceuticals serves customers in the State of California.
oricpharma.comTotal Amount Raised: $408,000,000
ORIC Pharmaceuticals Funding Rounds
Post Ipo Equity
$125,000,000
Post Ipo Equity
$125,000,000
Post Ipo Equity
$85,000,000
Post Ipo Equity Investors
Nextech InvestEcoR1 CapitalFrazier Life SciencesBoxer CapitalVenrock Healthcare Capital PartnersMontauk VenturesPost Ipo Equity
$85,000,000
Post Ipo Equity Investors
Nextech InvestEcoR1 CapitalFrazier Life SciencesBoxer CapitalVenrock Healthcare Capital PartnersMontauk VenturesPost Ipo Equity
$85,000,000
Post Ipo Equity Investors
Nextech InvestEcoR1 CapitalFrazier Life SciencesBoxer CapitalVenrock Healthcare Capital PartnersMontauk VenturesPost Ipo Equity
$25,000,000
Post Ipo Equity Investors
PfizerPost Ipo Equity
$25,000,000
Post Ipo Equity Investors
PfizerIPO
Unknown
Series D
$55,000,000
Series D Investors
ArrowMark Colorado HoldingsInvusEcoR1 CapitalThe Column GroupForesite CapitalKravis Investment PartnersFidelityTopspin PartnersCity Hill VenturesHartford Healthcare EndowmentOrbiMed AdvisorsMemorial Sloan Kettering Cancer CenterCasdin CapitalTaiho VenturesIrving InvestorsCorrelation VenturesSeries D
$55,000,000
Series D Investors
ArrowMark Colorado HoldingsInvusEcoR1 CapitalThe Column GroupForesite CapitalKravis Investment PartnersFidelityTopspin PartnersCity Hill VenturesHartford Healthcare EndowmentOrbiMed AdvisorsMemorial Sloan Kettering Cancer CenterCasdin CapitalTaiho VenturesIrving InvestorsCorrelation VenturesSeries C
$50,000,000
Series C Investors
FidelityTaiho VenturesForesite CapitalNS InvestmentThe Column GroupKravis Investment PartnersEcoR1 CapitalTrinitas CapitalTopspin FundOrbiMed AdvisorsMemorial Sloan Kettering Cancer CenterSeries C
$50,000,000
Series C Investors
FidelityTaiho VenturesForesite CapitalNS InvestmentThe Column GroupKravis Investment PartnersEcoR1 CapitalTrinitas CapitalTopspin FundOrbiMed AdvisorsMemorial Sloan Kettering Cancer CenterSeries B
$53,000,000
Series B Investors
The Column GroupTopspin PartnersOrbiMed AdvisorsEcoR1 CapitalForesite CapitalKKRSeries B
$53,000,000
Series B Investors
The Column GroupTopspin PartnersOrbiMed AdvisorsEcoR1 CapitalForesite CapitalKKRSeries A
$15,000,000
Series A Investors
The Column Group
Funding info provided by Diffbot.